Search Orphan Drug Designations and Approvals
-
Generic Name: | ganitumab |
---|---|
Date Designated: | 11/23/2010 |
Orphan Designation: | Treatment of pancreatic cancer. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
NantCell, Inc., a wholly-owned subsidiary of ImmunityBio, Inc. 9920 Jefferson Boulevard Culver City, California 90232 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-